The discrepancy between preoperative qPCR results for BRAF V600E and VE1 IHC findings prompted further investigation with Sanger sequencing, revealing a rare BRAF mutation (V600_K601insNTV) in the FTC case, as previously reported (15). This evidence concerns the gene BRAF and thyroid cancer, nonmedullary, 2.